EMPACT-MI at ACC.24, with Javed Butler, MD

In this episode of Don’t Miss a Beat, Javed Butler, MD, joins hosts Muthiah Vaduganthan, MD, MPH, and Steve Greene, MD, for a breakdown of the EMPACT-MI trial, including primary results, secondary findings, how data from DAPA-MI and EMPACT-MI complement each other, and what is next for the SGLT2 inhibitor class.  Key Highlights: 00:00 - Intro 01:57 - Trial Design and Results 07:00 - Inclusion Criteria and Patient Characteristics 10:53 - Primary Results of EMPACT-MI 14:34 - Subgroup Analyses 15:27 - Implications for Post-MI Patient Population  19:53 - Takehome Messages for Care 23:39 - Kidney Outcomes in Post-MI Patient Population

There are no comments yet.

Please log in to write the first comment.